Skip to content
Search

Latest Stories

NHS England begins at-home testing for chronic kidney disease

NHS England begins at-home testing for chronic kidney disease

The Healthy.io early detection device is expected to help detect 1,300 cases of undiagnosed chronic kidney disease (CKD) over the coming months.

 Thousands of patients at risk of developing kidney disease will be able to check their kidney function at home, as part of a new trail launched in West Yorkshire.


The trial will be supported by the £30million Health Technology Adoption and Accelerator Fund, launched by the Department of Health and Social Care and NHS England to reduce waiting lists and improve patient care.

An at-home self-testing kit developed by Healthy.io will be sent to 30,000 at-risk individuals, and this is predicted to help detect 1,300 cases of undiagnosed chronic kidney disease (CKD) over the coming months.

For checking the kidney function, the small device is placed in a urine sample and then scan it using an app, which gives immediate results on whether the patient may have a kidney condition. The test results are also instantly uploaded to the patient’s electronic medical record for clinical review.

Another scheme supported by the Fund will benefit hundreds of older adults in Norfolk and Waveney and North East London. They will be provided ‘Feebris kit’ which monitors blood pressure and heart rates, and alert their GP if they have a fall.

Health Secretary Victoria Atkins commented: “We provided £30 million this winter to roll out innovative medical technology to ease pressure on the NHS – and it’s already having an impact.

“This kidney disease device has saved lives and could help to identify thousands more cases – while hundreds of elderly patients will be able to identify health issues more quickly thanks to wearable technology.

“Moving forward, I’m focused on adopting the latest cutting-edge technology to ensure patients can receive faster and simpler care in the comfort of their homes and cut down on unnecessary trips to hospital.”

Other technologies made available to local NHS teams under this funding include BRAVE AI, Docobo and Whzan.

Dr Vin Diwakar, Medical Director for Transformation, said these innovations will not only benefit patients and staff, but also help keep people out of hospitals during the busy winter.

Verena Stocker, Interim Director of Innovation, Research, Life Sciences and Strategy, NHSE, too acknowledges that innovations help relieve pressure and provide early diagnosis, monitoring, and treatments.

“Innovations like those supported by this fund transform individual patient lives as well as bring significant benefits to the UK economy and to society as a whole,” she added.

Fiona Loud, Policy Director of Kidney Care UK, highlighted that about 3.5 million people in the UK have moderate to advanced kidney disease, but many of them are not aware of it.

The number of people with kidney disease is expected to grow significantly over the coming decade “because of an ageing population, increasing prevalence of type 2 diabetes and high blood pressure.”

“Yet detection is much lower than it should be, putting lives at risk and causing unnecessary pressure to the NHS,” Fiona added, while lauding the launch of the at-home kidney testing trail.

The National CKD Audit estimates that seven acute kidney injuries, six cardiovascular events, two ICU admissions and seven deaths could be avoided if 100 patients are prevented from developing moderate to severe CKD through early detection.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
​The next generation of BD Rowa Smart launched

The latest BD Rowa™ Smart introduces a more intuitive user interface.

Photo credit: BD Rowa

BD Rowa unveils next-generation smart dispensing robot with sustainable design

Leading medical technology company BD Rowa has announced the launch of the next generation of its smart dispensing robot, offering enhanced convenience with a sustainable design.

Currently in its final development phase, the latest BD Rowa™ Smart introduces a more intuitive user interface designed to streamline operations and enhance the user experience.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less